Makati

Philippines

Jakarta

Grogol Petamburan

Phone Number

0962 950 7814
(02) 8637-2360

Send Your Mail

slcelitemedicalcare@gmail.com

Inquire Now

Strontium-89 Therapy

  • Home
  • Strontium-89 Therapy

Strontium-89 Therapy: An Advanced Radiopharmaceutical Treatment for Bone Metastases

Strontium-89 (⁸⁹Sr) therapy is a systemic radiation treatment designed to target and alleviate painful bone metastases caused by advanced cancers. Administered as an intravenous injection of Strontium-89 chloride, this therapy selectively delivers beta radiation to areas of abnormal bone growth, providing effective and long-lasting pain relief for patients with metastatic disease.

Advantages of Strontium-89 Therapy

  • Bone-Seeking Properties: Strontium-89 behaves similarly to calcium, allowing it to naturally accumulate in areas of high bone turnover, such as cancerous lesions.
  • Localized Radiation Effect: Once absorbed, it emits beta particles that penetrate and destroy nearby cancer cells while minimizing exposure to healthy tissues.
  • Gradual & Sustained Relief: Pain reduction typically begins within 1–3 weeks after treatment, with effects lasting several months.
    Minimal Hospital Visits: Administered as a single outpatient infusion, reducing the need for repeated interventions.

How It Works

  • Injected intravenously, it mimics calcium and accumulates in bone (especially areas with rapid turnover, like tumors).
  • Emits beta radiation to destroy cancer cells and reduce nerve irritation.
  • Pain relief begins in 7–21 days, lasting 3–6 months.

Conditions Treated:

  1. Metastatic bone cancer (prostate, breast, lung primaries)
  2. Palliative care for patients unresponsive to conventional pain therapies

Key Benefits of Chemical Ablation

  • Non-invasive: No surgery or hospitalization required.
  • Targeted action: Minimal impact on healthy tissues.
  • Long-lasting relief: Reduces opioid dependence.
  • Combination-friendly: Works with chemo/hormone therapy.